Evidence map›Paper›PMID 31396362›Full record

ArticleAmerican journal of translational research2019

MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/β-catenin pathway via direct targeting of Frizzled 7 mRNA.

Fengqi Zhou, Wenping Cao, Ran Xu, Junxia Zhang, Tianfu Yu, Xiupeng Xu, Tongle Zhi, Jianxing Yin, Shengwu Cao, Ning Liu and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. RNA-Binding Proteins: Modulators of Canonical Wnt Signaling Pathway.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Non-Coding RNA and Frizzled Receptors in Cancer.Frontiers in molecular biosciences · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Fengqi ZhouDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Wenping CaoDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Ran XuDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Junxia ZhangDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Tianfu YuDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Xiupeng XuDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Tongle ZhiDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Jianxing YinDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Shengwu CaoDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Ning LiuDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Yingyi WangDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Chunsheng ZhaoDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, Jiangsu Province, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioma is one of the most prevalent primary malignant brain tumours among adults, and accumulating evidence has shown that dysregulation of microRNAs (miRNAs) is associated with various types of cancers, including glioma. It is necessary to gain a better understanding of the roles and mechanisms of action of miRNAs in WNT-driven glioblastoma multiforme (GBM). Here, we report that miR-206 inhibits the WNT/β-catenin pathway by directly targeting Frizzled 7 (

Indexed as

FZD7gliomainvasionmiR-206proliferation

Identifiers

PMID31396362
PMCPMC6684916
OpenAlexW2993071643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.